article thumbnail

3 Barriers Between Patients and Clinical Research

Find Me Cure

As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .

article thumbnail

Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test

XTalks

The study was funded by a clinical research agreement with the NBA and the players’ union – the National Basketball Players Association (NDG) – which together, contributed over $500,000 to fund the Yale study. Last month, the FDA approved a pooled test for COVID-19 developed by Quest Diagnostics. It’s sensitive.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

And this year Eli Lilly stepped into the obesity drug market with its own GLP-1 weight loss drug Zepbound (tirzepatide), which the US Food and Drug Administration (FDA) approved in November of this year. GSK Canada chose Gretzky for his iconic status and the influence he has on the Canadian public, especially those over 60.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

article thumbnail

Can psychedelics provide breakthrough in mental health?

pharmaphorum

Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharma companies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

article thumbnail

Digital tools driving innovative clinical trials

pharmaphorum

Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. It needs to be performed with a benchmark, an FDA-approved device.”. Novel digital endpoints. About the interviewees.

article thumbnail

The Unprecedented Growth of Cell and Gene Therapy (2021)

Cloudbyz

increase in CGT clinical trials. Segregation of cell and gene therapy conducted during 2020, based on clinical trial phases (Source: Alliance for Regenerative Medicine ) As of date, the FDA approved only 7 cell and gene therapy drugs, however, the product pipeline included ~1,200 experimental therapies.